Atient access programs. Lenalidomide Although not FDA-approved, lenalidomide is another targeted
Chemexpress Atient access applications. Lenalidomide Although not FDA-approved, lenalidomide is yet another targeted agent that has shown promising clinical activity in CLL patients.28,29 However, the frontline study evaluating lenalidomide vs chlorambucil…